Find A Research Study
Study Name: CombiRx
Category: Neurology
Currently accepting participants?
Yes - please read the description below and contact the study coordinator if you are interested.
Principal Investigator: Mariko Kita
Study Coordinator: Allison Singer
Phone: 206-625-7373 Ext.64923
Email: allison.singer@vmmc.org
What is the CombiRx study?
The study is being conducted to compare the
combined use of Interferon Beta-1a and Glatiramer
Acetate to either agent alone in patients with
Relapsing Remitting Multiple Sclerosis (RRMS)
Who can participate?
People ages 18 and 60, who have been diagnosed
with Relapsing Remitting Multiple Sclerosis.
with Relapsing Remitting Multiple Sclerosis.
What do I have to do as a study participant?
If eligible, you will be asked to come to
Virginia Mason Medical Center for a variety of
procedures that may include: physical exams,
neurological exams, blood draws, ECGs, MRIs, and
injection training to administer the study
drugs. The study will last 3 years.
Virginia Mason Medical Center for a variety of
procedures that may include: physical exams,
neurological exams, blood draws, ECGs, MRIs, and
injection training to administer the study
drugs. The study will last 3 years.
Other studies in this category include:
Studies currently accepting study participants:
- CombiRx
- Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis II
- Novartis Fingolimod MS Study
- Relapsing - Remitting MS: A Placebo-Controlled and Active Reference (Glatiramer Acetate) Comparison Study to Evaluate the Efficacy and Safety of oral BG00012
Studies currently not accepting study participants:
No studies currently listed. Please try another category.